Skip to content

Anxiety, Depression, Fatigue, and Quality of Life Outcomes Following a Movement-Based Mindfulness or Social Group Program for Chronic Stroke: A Sub-Study of a Phase II Feasibility Randomised Controlled Trial

Shaun Hancock, Tharshanah Thayabaranathan, Rene Stolwyk, J. Cameron, Maarten A. Immink, Susan Hillier, Monique Femia Kilkenny, Amy Brodtmann, Leeanne M. Carey, M. Olaiya, Emma K. C. Gee, Dominique A Cadilhac

Mindfulness May 3, 2025 DOI: 10.1007/s12671-025-02579-8 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Preregistered Peer reviewed
Sample size 38
Population Adults 3–18 months post-stroke; 72% male, median age 70 years
Intervention Movement-based mindfulness
Duration 12-week intervention; follow-up at 13–15 weeks post-baseline
Topics Anxiety Depression Meditation
Key findings Both movement-based mindfulness and social group classes produced small-to-medium within-group improvements in anxiety, depression, fatigue, and health-related quality of life, with no statistically significant between-group differences. The authors suggest these programs may be beneficial post-stroke and warrant further investigation.

Abstract

Movement-based mindfulness may be beneficial for mental health and health-related quality of life (HRQoL) post-stroke. We assessed changes in anxiety, depression, fatigue, and HRQoL in survivors of stroke participating in movement-based mindfulness intervention against an attention control (social group). Participants were between 3- and 18-months post-stroke and randomised 1:1 to the movement-based mindfulness intervention or social group (15-20 min lifestyle education then socialisation). Each program was delivered as group-based, 1-hr classes over 12 weeks. Anxiety, depression, fatigue, and HRQoL were measured at baseline and post-intervention (13–15 weeks post-baseline). Within-group changes were analysed using Cohen’s d. The magnitude of change was classified as small (d = 0.2), medium (d = 0.50), or large (d = 0.80). Between-group differences were assessed using generalised linear mixed models. Thirty-eight participants were randomised, and 36 completed follow-up (72% male, median age 70 years). Movement-based mindfulness showed greater within-group effects than attention control for HRQoL (d = 0.22 vs d = 0.18) and aspects of HRQoL (e.g. memory (d = 0.31 vs d = 0.06), and mobility (d = 0.45 vs d = 0.37). Movement-based mindfulness showed smaller within-group effect than attention control for anxiety (d = 0.25 vs d = 0.46), depression (d = 0.11 vs d = 0.48), and aspects of HRQoL (e.g. communication (d = 0.01 vs d = 0.46), usual activities (d = 0.11 vs d = 0.40), hand function (d = 0.04 vs d = 0.43), and utility score (d = 0.02 vs d = 0.34)). No between-group differences were found. Movement-based mindfulness or social group classes provide small-to-medium favourable changes in various health domains within 3–18 months of stroke. These findings support further investigation of these programs. The conducted research was pre-registered with The Australian and New Zealand Registry: ACTRN12620000105943.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics